Client News

Expedeon AG announces conversion to registered shares

Rentschler Biopharma announces enhanced collaboration with Summit Pharmaceuticals International Corporation to expand Japanese operation-base

Motif Bio plc: Change of Adviser

Heidelberg Pharma AG announces adjustment of guidance

Adocia Announces Receipt of USD 14.3 million Payment from Eli Lilly Following Arbitration Conclusion and the Decision by Mutual Consent with Eli Lilly to Conclude the Civil Case

Biom’up: Approval of 2019 H1 interim results postponed – Board of Directors pursues review of options available to the Company

Motif Bio plc: Motif Bio Reports Half-Year 2019 Financial Results, Operational Progress and Proposed Initiatives

Adrenomed completes full enrollment with 300 patients in AdrenOSS-2 trial with Adrecizumab in septic shock

Biocrates Life Sciences AG and Helmholtz Zentrum München Celebrate 10 Years of Partnership in Personalized Medicine

APEIRON to present preclinical APN401 data at the 2019 ESMO Congress